On Monday shares of Regions Financial Corporation (NYSE:RF) closed at $10.21. Company’s sales growth for last 5 years was -7.40% and EPS growth for next 5 years is recorded as 6.03%. Sandler O’Neill reaffirmed their buy rating on shares ofRead More
On Monday shares of Lakeland Industries Inc. (NASDAQ:LAKE) closed at $10.47. Company’s sales growth for last 5 years was -2.10% and EPS growth for next 5 years is recorded as 10.00%. On May 18, Lakeland Industries, Inc. (NASDAQ: LAKE), announcedRead More
On Monday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $14.20. Sorrento Therapeutics (NASDAQ:SRNE)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainright in a research report issued on Friday. They currently have a $20.00 target priceRead More
On Monday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $3.34. May 15, CymaBay Therapeutics Inc. (NASDAQ:CBAY) announced that Harold Van Wart, Ph.D., President and Chief Executive Officer, will present a corporate update at the 2015 UBS Global Healthcare ConferenceRead More
On Monday shares of OXiGENE, Inc. (NASDAQ:OXGN) closed at $1.39. On May 12, OXiGENE, Inc. (NASDAQ:OXGN) announced the appointment of a new President and Chief Executive Officer, Bill Schwieterman, M.D. The company’s current CEO, Dai Chaplin, Ph.D., will become ChiefRead More
On Monday shares of Athersys, Inc. (NASDAQ:ATHX) closed at $1.33. Company’s sales growth for last 5 years was -6.20% and EPS growth for next 5 years is recorded as 28.00%. Athersys Inc. (NASDAQ:ATHX) on May 11 reported a loss ofRead More
On Monday shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) closed at $20.27. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) announced the commencement of a proposed underwritten public offering of 2,750,000 shares of common stock. Dicerna also intends to grant the underwriters a 30-day optionRead More
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) in last trading activity advanced 3.84% to close at $20.27. Company weekly performance is -10.51% while its quarterly performance stands at -5.98%. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) is -25.83% away from its 52 week high. Dicerna Pharmaceuticals,Read More
On Monday shares of NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) closed at $0.63. Company’s sales growth for last 5 years was -41.20%. On May 14, NovaBay® Pharmaceuticals, Inc. (NYSEMKT:NBY), reported financial results for the three months ended March 31, 2015, and providedRead More
On Monday shares of Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) closed at $1.15. Company’s sales growth for last 5 years was 2.90%. Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) announced its operating results for the first quarter of 2015.The Company reported top line sales ofRead More
